Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Unraveling the Relation of Patient's Profile and Therapeutical Effects of Atypicals, Including Quetiapine Effect (UPTAQE)

This study has been completed.
Sponsor:
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00534222
First received: September 20, 2007
Last updated: December 13, 2011
Last verified: April 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2007
  Estimated Primary Completion Date: No date given